Scientists test 'Supercharged' immune cells against blood cancers
NCT ID NCT00709033
Summary
This early-phase study tested a new gene therapy approach for patients whose non-Hodgkin lymphoma or chronic lymphocytic leukemia had returned or didn't respond to standard treatments. Researchers modified patients' own immune T-cells in the lab to better recognize and attack their cancer cells, then infused them back into the patients. The main goals were to find a safe dose, see how long the modified cells lasted in the body, and check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.